Margaret Koziel, M.D.

Margaret Koziel, M.D.

Chief Medical OfficeratInnoviva· In the 2023 proxy

Pay in FY2023Innoviva stock +21.1% the same year

Margaret Koziel, M.D. was paid $967.7K in FY2023 (Dec). Innoviva stock rose 21.1% that year.

Pay$100 in the stock at the end of FY22 → $121
Pay is from the Summary Compensation Table of each Innoviva proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. InnovivaPublic company · 3 yr
    • Chief Medical Officer2023 – Present · 3 yrStock in role +60%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?